128 related articles for article (PubMed ID: 15548127)
1. Managed care market perspectives on the over-the-counter availability of statins.
Richards MK; Blumenfield S; Lyon RA
J Manag Care Pharm; 2004; 10(6):543-50. PubMed ID: 15548127
[TBL] [Abstract][Full Text] [Related]
2. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
[TBL] [Abstract][Full Text] [Related]
3. Consumer behavior in the setting of over-the-counter statin availability: lessons from the consumer use study of OTC Mevacor.
Brass EP
Am J Cardiol; 2004 Nov; 94(9A):22F-29F. PubMed ID: 15519288
[TBL] [Abstract][Full Text] [Related]
4. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.
Sullivan PW; Nichol MB
Value Health; 2004; 7(4):402-12. PubMed ID: 15449632
[TBL] [Abstract][Full Text] [Related]
5. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
Nemlekar P; Shepherd M; Lawson K; Rush S
J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability.
Trygstad TK; Hansen RA; Wegner SE
J Manag Care Pharm; 2006 Mar; 12(2):108-20. PubMed ID: 16515369
[TBL] [Abstract][Full Text] [Related]
8. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
Harris BN; West DS; Johnson J; Hong SH; Stowe CD
J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.
Greenapple R
Am Health Drug Benefits; 2012 Jul; 5(4):242-53. PubMed ID: 24991323
[TBL] [Abstract][Full Text] [Related]
10. Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers.
Lopata E; Terrone C; Gopalan A; Ladikos N; Richardson T
J Manag Care Spec Pharm; 2021 Jun; 27(6):706-713. PubMed ID: 33586514
[No Abstract] [Full Text] [Related]
11. A cost-effectiveness analysis of over-the-counter statins.
Stomberg C; Albaugh M; Shiffman S; Sood N
Am J Manag Care; 2016 May; 22(5):e294-303. PubMed ID: 27266585
[TBL] [Abstract][Full Text] [Related]
12. The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?
McKenney JM; Brown WV; Cohen JD; Cahill E
Am J Cardiol; 2004 Nov; 94(9A):16F-21F. PubMed ID: 15519287
[TBL] [Abstract][Full Text] [Related]
13. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly?
Francis SA; Barnett N; Denham M
Drugs Aging; 2005; 22(5):361-70. PubMed ID: 15903349
[TBL] [Abstract][Full Text] [Related]
14. Impact of a policy allowing for over-the-counter statins.
Mainous AG; Baker R; Everett CJ; King DE
Qual Prim Care; 2010; 18(5):301-6. PubMed ID: 21114910
[TBL] [Abstract][Full Text] [Related]
15. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
Johnson JT; Neill KK; Davis DA
J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
[TBL] [Abstract][Full Text] [Related]
16. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
Kalish SC; Bohn RL; Avorn J
Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
[TBL] [Abstract][Full Text] [Related]
17. Attitudes towards sales and use of over-the-counter drugs in Sweden in a reregulated pharmacy market: a population-based study.
Hedenrud T; Andersson Sundell K; Martinsson J; Håkonsen H
Int J Pharm Pract; 2019 Feb; 27(1):17-24. PubMed ID: 29687513
[TBL] [Abstract][Full Text] [Related]
18. Pharmacy benefit management companies.
Taniguchi R
Am J Health Syst Pharm; 1995 Sep; 52(17):1915-7. PubMed ID: 8528857
[TBL] [Abstract][Full Text] [Related]
19. Potential impact on cardiovascular public health of over-the-counter statin availability.
Brass EP; Allen SE; Melin JM
Am J Cardiol; 2006 Mar; 97(6):851-6. PubMed ID: 16516588
[TBL] [Abstract][Full Text] [Related]
20. Over-the-counter medications and self-care.
Lowe NK; Ryan-Wenger NM
Nurse Pract; 1999 Dec; 24(12):34-44. PubMed ID: 10635517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
